107 related articles for article (PubMed ID: 9494566)
1. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer.
Katano K; Tsujitani S; Maeta M; Fukuda K; Oka S; Hisamitsu K; Ikeguchi M; Kaibara N
Oncol Rep; 2001; 8(3):605-9. PubMed ID: 11295088
[TBL] [Abstract][Full Text] [Related]
4. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
[TBL] [Abstract][Full Text] [Related]
5. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
Kondo A; Maeta M; Oka A; Tsujitani S; Ikeguchi M; Kaibara N
Br J Cancer; 1996 May; 73(10):1166-70. PubMed ID: 8630273
[TBL] [Abstract][Full Text] [Related]
6. Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results.
Ichinose Y; Hara N; Ohta M; Asoh H; Yano T; Maeda K; Yagawa K
J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1041-6. PubMed ID: 8388966
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
Isambert N; Correia M; Cercueil JP; Zanetta S; Osmak L; Flesch M; Krause D; Coudert B; Fargeot P; Bedenne L; Chauffert B
J Exp Clin Cancer Res; 2001 Jun; 20(2):183-8. PubMed ID: 11484972
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
Lardinois D; Jung FJ; Opitz I; Rentsch K; Latkoczy C; Vuong V; Varga Z; Rousson V; Günther D; Bodis S; Stahel R; Weder W
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):697-703. PubMed ID: 16515926
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effect of intraperitoneal hyperthermic and hypotonic chemotherapy on ascites cancer cells in mice].
Chen Z; Peng D; Tan J
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):101-4. PubMed ID: 7657323
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
14. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
[TBL] [Abstract][Full Text] [Related]
16. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
17. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
19. [Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials].
Hagiwara A; Takahashi T; Yamaguchi T; Taniguchi H; Iwamoto A; Yoneyama C; Ito M; Sasabe T; Lee M; Wada R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1575-8. PubMed ID: 2389951
[TBL] [Abstract][Full Text] [Related]
20. The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer.
Tsujitani S; Fukuda K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Surgery; 2002 Jan; 131(1 Suppl):S98-104. PubMed ID: 11821794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
